Robert LeBoyer
Stock Analyst at Noble Capital Markets
(0.26)
# 2530
Out of 5,329 analysts
20
Total ratings
31.25%
Success rate
2.32%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TNXP Tonix Pharmaceutical... | Reiterates: Outperform | 70 70 | 19.39 | 261.01% | 2 | Mar 20, 2025 | |
NTRB Nutriband | Initiates Coverage On: Outperform | 13 | 6.36 | 104.4% | 1 | Jan 22, 2025 | |
GOVX Geovax Labs | Maintains: Outperform | 6 10 | 1.01 | 890.1% | 2 | Aug 19, 2024 | |
UNCY Unicycive Therapeuti... | Initiates Coverage On: Outperform | 6 | 0.66 | 809.09% | 1 | Feb 14, 2024 | |
CVKD Cadrenal Therapeutic... | Initiates Coverage On: Outperform | 60 | 16.4 | 265.85% | 1 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 10 | 3.33 | 200.3% | 1 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | 2.33 | 500.86% | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 150 | n/a | n/a | 1 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 0.47 | 1602.13% | 2 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 120 | 0.63 | 18947.62% | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 9.44 | 27.12% | 1 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 825000 | n/a | n/a | 1 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 2.28 | 557.89% | 2 | Mar 8, 2018 |